Lisa J. McGarry - Concepedia

Author

Lisa J. McGarry

Vertex Pharmaceuticals (United States)ORCID

Also Known As

L McGarry, L. J. McGARRY, L. J. McGarry, L. McGarry, L. Mcgarry, L.J. McGarry, LISA J. MCGARRY, Liam McGarry, Lisa J McGarry, Lisa J. McGarry

115

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Vertex Pharmaceuticals (United States)Harvard University Optum (United States)HealthInsight Ariadne Diagnostics (United States)

About

Lisa J. McGarry is an author at Vertex Pharmaceuticals (United States) specializing in medicine, health economics, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	357
2	Health Sciences	2	2	51
3	Public Health	1	1	102
4	Epidemiology	1	1	102
5	Immunology	1	1	204

Lisa J. McGarry

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). Larry S. McDaniel, Janet Yother, M N Vijayakumar, The Journal of Experimental Medicine Medical MicrobiologyPspa Structural GenePspa- MutantsVirulence FactorPathogenesis	1987	204
Outcomes and Costs of Acute Treatment of Traumatic Brain Injury Lisa J. McGarry, David R. Thompson, Frederick H. Millham, The Journal of Trauma: Injury, Infection, and Critical Care	2002	195
All-Cause and Incremental Per Patient Per Year Cost Associated with Chronic Hepatitis C Virus and Associated Liver Complications in the United States: A Managed Care Perspective Carrie McAdam‐Marx, Lisa J. McGarry, Christopher A. Hane, Journal of Managed Care Pharmacy	2011	166
Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome‐positive leukemias with the T315I mutation Franck E. Nicolini, Grzegorz Basak, Dong‐Wook Kim, Cancer	2017	131
Economic model of a birth cohort screening program for hepatitis C virus Lisa J. McGarry, Vivek Pawar, H. Panchmatia, Hepatology	2011	112
Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States Jaime Rubin, Lisa J. McGarry, David Strutton, Vaccine VaccinationPreventive MedicineHealth EconomicsMedicineEconomic Impact	2010	102
A Randomized Trial of Controlled-Release Oxycodone During Inpatient Rehabilitation Following Unilateral Total Knee Arthroplasty Andrea Cheville, Alice P. Chen, Gerry Oster, Journal of Bone and Joint Surgery	2001	97
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Lisa J. McGarry, David R. Thompson, Milton C. Weinstein, PubMed	2004	80
Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States Karen M. Clements, Genevieve Meier, Lisa J. McGarry, Human Vaccines & Immunotherapeutics	2014	59
Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients Lisa J. McGarry, Michael E. Stokes, David R. Thompson Thrombosis Journal	2006	53

Page 1